Search Results - deborah+krakow

1 Results

Sort By:

Increasing Linear Growth in Osteogenesis Imperfecta (UCLA Case No. 2025-258)

UCLA researchers from the Department of Orthopedic Surgery, OBGYN, and Human Genetics have identified the drug infigratinib as a potential therapeutic to treat osteogenesis imperfecta (OI). BACKGROUND: Osteogenesis Imperfecta (OI) is a heterogeneous genetic condition that can be characterized by brittle bones, recurrent fractures, and short stature....

Published: 10/1/2025 | Inventor(s): Deborah Krakow

Keywords(s):

Category(s): Therapeutics > Musculoskeletal Disease